` 8QQ (Abcellera Biologics Inc) vs DAX Index Comparison - Alpha Spread

8QQ
vs
D
DAX Index

Over the past 12 months, 8QQ has underperformed DAX Index, delivering a return of -16% compared to the DAX Index's +9% growth.

Stocks Performance
8QQ vs DAX Index

Loading
8QQ
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
8QQ vs DAX Index

Loading
8QQ
DAX Index
Difference
www.alphaspread.com

Performance By Year
8QQ vs DAX Index

Loading
8QQ
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Abcellera Biologics Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Abcellera Biologics Inc
Glance View

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

8QQ Intrinsic Value
0.7 EUR
Overvaluation 73%
Intrinsic Value
Price
Back to Top